Fosun Pharma Announces 2022 Annual Results: Achieved Steady Growth with Revenue from Record High Innovative Products and Global Commercialization Capability Improvement

Shanghai Fosun Pharmaceutical Co., Ltd.*, a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China, announced its 2022 annual results.